Post by
cashflow98 on Dec 04, 2015 12:36pm
NY Post article Dec.4 by Michelle Celarier
Not CXR but related. Hope the Drug Lobby does what its paid to do.... Valeant Chief Executive Michael Pearson will not testify at next weeks Senate subcommittee hearing on drug pricing. Last month, Sens. Susan Collins (R-Maine) and Claire McCaskill (D-Mo.), who together lead the Senate Special Committee on Aging, announced plans for a December hearing as part of a Senate probe into drug pricing. At that time, they asked for information on pricing from four drug companies, including Valeant. Valeant said it submitted documents to the senators. Pearson also offered to testify, but he wasnt called on, in part because the senators realize high drug prices are an industry-wide problem, sources said. The pharmaceutical lobby, one of the biggest spenders in Washington, has been fending off efforts by the government to negotiate drug prices for Medicare and ObamaCare patients for years.
Comment by
Bullphighter on Dec 04, 2015 12:48pm
These "lobbyist" The Hillarys of the world, just do not live in reality. Let the US government form their own company and find how the tax payers feel about that! Formulas for LIFE saving medications do not come cheap. I wonder what Hillarys grandparents sold and what profits they enjoyed. Go check your email sweetie, grrrrrr Hillary
Comment by
cashflow98 on Dec 04, 2015 1:08pm
An interesting link below to lobbyist dollar spend per company. Check out where Valiant is on this list. Would be interesting to co-relate this list with profits/stock prices by company.... https://www.opensecrets.org/lobby/indusclient.php?id=h04